An Open Label, Dose Escalation Study of ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects

Trial Profile

An Open Label, Dose Escalation Study of ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Nov 2016

At a glance

  • Drugs ACH 04 (Primary)
  • Indications Diarrhoea
  • Focus Adverse reactions; First in man
  • Sponsors Ache Laboratories
  • Most Recent Events

    • 08 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top